Article Details
Retrieved on: 2024-05-29 17:51:40
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the discovery of the lipid-lowering effects of nesfatin-1-like peptide (NLP) by Suraj Unniappan and his team, emphasizing its potential in treating metabolic diseases. This connects to 'biopharma' and tags such as 'Proteins, Lipid metabolism, and Liver disease', highlighting advances in understanding lipid disorders and developing new therapies.
Article found on: www.labmanager.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here